Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · Real-Time Price · USD
6.71
-1.19 (-15.06%)
Mar 3, 2025, 4:00 PM EST - Market closed
Cryo-Cell International Revenue
In the fiscal year ending November 30, 2024, Cryo-Cell International had annual revenue of $31.99M with 2.05% growth. Cryo-Cell International had revenue of $8.02M in the quarter ending November 30, 2024, with 1.87% growth.
Revenue (ttm)
$31.99M
Revenue Growth
+2.05%
P/S Ratio
2.01
Revenue / Employee
$363,478
Employees
88
Market Cap
54.08M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Nov 30, 2024 | 31.99M | 642.41K | 2.05% |
Nov 30, 2023 | 31.34M | 1.01M | 3.32% |
Nov 30, 2022 | 30.34M | 1.45M | 5.03% |
Nov 30, 2021 | 28.88M | -2.26M | -7.26% |
Nov 30, 2020 | 31.15M | -668.98K | -2.10% |
Nov 30, 2019 | Pro | Pro | Pro |
Nov 30, 2018 | Pro | Pro | Pro |
Nov 30, 2017 | Pro | Pro | Pro |
Nov 30, 2016 | Pro | Pro | Pro |
Nov 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
CCEL News
- 4 weeks ago - Cord Blood Banking Leader Cryo-Cell Announces Regular Quarterly Cash Dividend and Pause of Strategic Initiatives - Business Wire
- 4 months ago - Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend - Business Wire
- 4 months ago - Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results - Business Wire
- 8 months ago - Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2024 Financial Results - Business Wire
- 11 months ago - Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results - Business Wire
- 1 year ago - Cryo-Cell Announces Plans to Explore Strategic Alternatives and Spin-off Celle Corp. to Maximize Shareholder Value - Business Wire
- 1 year ago - Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2023 - Business Wire
- 1 year ago - Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2023 Financial Results - Business Wire